Costs and Its Determinants in Pituitary Tumour Surgery.

ABSTRACT:

Purpose

Value-based healthcare (VBHC) provides a framework to improve care by improving patient outcomes and reducing healthcare costs. To support value-based decision making in clinical practice we evaluated healthcare costs and cost drivers in perioperative care for pituitary tumour patients.

Methods

We retrospectively assessed financial and clinical data for surgical treatment up to the first year after surgery of pituitary tumour patients treated between 2015 and 2018 in a Dutch tertiary referral centre. Multivariable regression analyses were performed to identify determinants of higher costs.

Results

271 patients who underwent surgery were included. Mean total costs (SD) were €16339 (13573) per patient, with the following cost determinants: surgery time (€62 per

SUBMITTER: Dekkers AJ 

PROVIDER: S-EPMC9302462 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature